16.04
Surgery Partners Inc stock is traded at $16.04, with a volume of 10.57M.
It is down -25.42% in the last 24 hours and down -18.77% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$21.50
Open:
$17.75
24h Volume:
10.57M
Relative Volume:
8.13
Market Cap:
$2.06B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-59.39
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-26.11%
1M Performance:
-18.77%
6M Performance:
-27.64%
1Y Performance:
-47.18%
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SGRY
Surgery Partners Inc
|
16.04 | 2.76B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
459.30 | 108.76B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
194.68 | 18.04B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.70 | 13.91B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
222.63 | 14.59B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
115.17 | 11.60B | 5.51B | 494.70M | 386.40M | 4.84 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Why Surgery Partners Stock Plummeted on Monday - Yahoo Finance
Surgery Partners Inc (SGRY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Surgery Partners price target lowered to $24 from $28 at BofA - TipRanks
Strategic Divestitures and Financial Leverage: A Buy Rating for Surgery Partners - TipRanks
Surgery Partners revises 2025 outlook to $3.275B-$3.3B revenue amid capital deployment delays and volume softness - MSN
Surgery Partners, Inc. Provides Earnings Guidance for the Full Year of 2025 - MarketScreener
Surgery Partners stock price target lowered to $24 by BofA Securities - Investing.com India
Why Surgery Partners (SGRY) Stock Is Trading Lower Today - Yahoo Finance
Surgery Partners: Q3 Earnings Snapshot - Connecticut Post
Earnings call transcript: Surgery Partners Q3 2025 results miss expectations - Investing.com India
Surgery Partners Stock Tumbles Amid Leadership Shakeup - TipRanks
Surgery Partners Shares Plunge Over 11% After Slashing 2025 Guidance and Missing Q3 Estimates - MSN
Surgery Partners Q3 Adjusted Net Income Declines, Revenue Increases; 2025 Revenue Outlook Lowered - 富途牛牛
Surgery Partners (SGRY) Q3 Earnings and Revenues Lag Estimates - sharewise.com
Earnings call transcript: Surgery Partners Q3 2025 results miss expectations By Investing.com - Investing.com Canada
Surgery Partners stock hits 52-week low at $17.75 - Investing.com
Surgery Partners SGRY Q3 2025 Earnings Transcript - The Globe and Mail
Surgery Partners, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Surgery Partners Misses Estimates But Keeps Growth In Focus - Finimize
Surgery Partners Inc earnings missed by $0.08, revenue fell short of estimates - Investing.com
Surgery Partners shares tumble over 11% after 2025 guidance cut By Investing.com - Investing.com Philippines
Surgery Partners (NASDAQ:SGRY) Posts Q3 Sales In Line With Estimates But Stock Drops 13.5% - Yahoo Finance
Surgery Partners shares tumble over 11% after 2025 guidance cut - Investing.com
Earnings Flash (SGRY) Surgery Partners, Inc. Reports Q3 Revenue $821.5M, vs. FactSet Est of $820.0M - MarketScreener
Surgery Partners Reports Third Quarter 2025 Financial Results with Revenue Growth and Adjusted EBITDA Increase - Quiver Quantitative
Earnings Flash (SGRY) Surgery Partners, Inc. Posts Q3 Adjusted EPS $0.13 per Share, vs. FactSet Est of $0.20 - MarketScreener
Surgery Partners, Inc. Announces Third Quarter 2025 Results - The Manila Times
Surgery Partners misses Q3 revenue estimates, cuts FY forecast - MarketScreener
Is Surgery Partners Inc. stock attractive for income investors2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
Applying sector rotation models to Surgery Partners Inc.2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Surgery Partners Inc. stock momentum explained2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Surgery Partners (SGRY): Examining Valuation Potential After Recent Share Rebound - simplywall.st
Surgery Partners (SGRY): Assessing Valuation After Recent Share Price Rebound - Yahoo Finance
Can Surgery Partners Inc. stock sustain market leadershipJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
Using RSI to spot recovery in Surgery Partners Inc.Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
Surgery Partners Earnings: What To Look For From SGRY - MSN
The Technical Signals Behind (SGRY) That Institutions Follow - news.stocktradersdaily.com
Surgery Partners Q3 2025 Earnings Preview - MSN
Will Surgery Partners Inc. benefit from macro trendsJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - newser.com
Developing predictive dashboards with Surgery Partners Inc. dataPortfolio Return Report & Step-by-Step Trade Execution Guides - newser.com
Why Surgery Partners Inc. stock is favored by top institutionsStop Loss & Short-Term High Return Strategies - newser.com
Is Surgery Partners Inc. meeting your algorithmic filter criteria2025 Valuation Update & High Yield Stock Recommendations - newser.com
Is Surgery Partners Inc. stock a top pick in earnings seasonEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Will Surgery Partners Inc. stock rally after Fed decisionsJuly 2025 Drop Watch & Proven Capital Preservation Tips - Fundação Cultural do Pará
What data driven models say about Surgery Partners Inc.’s futureEntry Point & Low Risk High Win Rate Picks - newser.com
Surgery Partners Inc. stock daily chart insights2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com
Surgery Partners Inc. stock trend outlook and recovery path2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Is Surgery Partners Inc. stock recession proofJuly 2025 Short Interest & Consistent Income Trade Recommendations - newser.com
Automated trading signals detected on Surgery Partners Inc.Options Play & Step-by-Step Trade Execution Guides - newser.com
Earnings Beat: Why Surgery Partners Inc. stock attracts high net worth investorsWeekly Profit Summary & AI Based Buy and Sell Signals - Fundação Cultural do Pará
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):